Personality Pharmacology

Part V · Pharmacology of the Self Draft

Chapter 28

Why Humans Self-Modify

Why do humans so persistently seek altered states?

The usual explanations are fragmented by discipline. Medicine speaks of self-medication. Addiction science speaks of reinforcement. Anthropology speaks of ritual. Economics speaks of preference. Psychiatry speaks of coping. Religious traditions speak of transcendence. Performance cultures speak of optimization.

These may be different names for overlapping movements through the same psychological landscape.

A person experiences a baseline. The baseline may feel anxious, inhibited, flat, distractible, emotionally intense, rigid, exhausted, lonely, self-conscious, or merely ordinary. The person discovers an intervention that moves the state somewhere else. The new region may be more pleasurable, more functional, more social, more meaningful, less painful, or simply unfamiliar.

They return.

This is self-modification in its broadest sense.

The intervention need not be a drug. Caffeine changes arousal. Running changes mood and attention. Fasting changes metabolic state and subjective experience. Meditation alters attention and self-processing. Music regulates emotion. Sex changes arousal and attachment. Sleep deprivation can produce unusual energy or cognition. Social immersion changes inhibition and reward. Solitude changes information flow. Competition mobilizes status and stress systems. Ritual synchronizes people and creates meaning.

Psychoactive substances are unusually powerful because they can move several dimensions rapidly and with relatively little behavioral effort.

The motive is not always symptom relief.

A shy person may use alcohol because it produces sociability. A tired person uses caffeine to become cognitively available. A rigid person may seek psychedelics because they value psychological openness. A highly emotional person may seek cannabis, sedatives, or dissociation because distance feels like relief. A person with low drive may seek stimulants because ordinary goals finally become compelling. Another seeks opioids because social and emotional pain temporarily lose their force.

starting pointreaches forto becomeshyalcoholsociabletiredcaffeinecognitively availablerigidpsychedelicsmore openhighly emotionalcannabis,sedativesat a distance fromfeelinglow in drivestimulantsmoved by ordinarygoalsin social oremotional painopioidsout of that pain for awhile
Figure 28.1Who do you become? Asking what a person becomes on a substance often points to the dimension they are compensating for.

The useful clinical question is often not “Why do you take this?” but “Who do you become when you take it?”

That question points toward the baseline dimension being compensated for.

This expands self-medication theory. A person can self-medicate a disorder, but they can also self-modify a trait they do not consider pathological. They may want more confidence, less caution, more intimacy, less empathy, stronger focus, weaker self-consciousness, or greater access to play.

The distinction between treatment and enhancement begins to blur at the motivational level long before medicine acknowledges it.

Several motives should be kept separate.

Treatment seeks relief from suffering or impairment. Compensation supplies a function without necessarily changing its underlying cause. Enhancement seeks performance or experience beyond a conventional baseline. Exploration samples alternative states to learn what is possible. Ritual creates a socially shared mode. Escape suppresses contact with unwanted experience. Identity experimentation asks whether another mode feels more congruent with the person one wants to be.

One episode can contain all of them.

The same substance can also move from one motive to another over time. A stimulant begins as a tool for work, becomes a preferred social state, and later becomes difficult to stop. Alcohol begins as relief from inhibition and gradually becomes necessary to feel normal. A psychedelic begins as exploration and becomes part of a metaphysical identity.

This is where agency becomes the central variable.

Self-modification expands agency when it gives the person access to useful states they could not otherwise reach and leaves them able to choose when to enter and exit. It reduces agency when the intervention becomes compulsory, narrows behavior around one reward, destabilizes other domains, or changes preferences in ways the person can no longer evaluate from outside the state.

Frequency alone does not capture this distinction. A daily cup of coffee can be habitual without meaningfully reducing agency. Infrequent binge use can create enormous loss of control. The relevant question is whether the person governs the state transition or the state transition governs the person.

Evolution may have prepared humans for state seeking long before purified drugs existed. Exercise, fasting, pain, social bonding, collective movement, sex, competition, isolation, sleep loss, and ritual all recruit endogenous systems capable of changing perception, arousal, reward, and affiliation. Culture learned to manipulate those levers and later discovered exogenous substances that could do so more directly.

This suggests that the desire to alter consciousness is not an aberration. It may be a predictable property of a brain capable of representing alternative states and learning how to reach them.

The clinical implication is not that every drug use is healthy. It is that moralizing altered-state seeking can obscure the function the behavior serves. If a person repeatedly chooses one state, the preference contains information.

Sometimes the information is that the baseline hurts.

Sometimes it is that the altered state feels extraordinarily rewarding.

Sometimes it is that the person has discovered a version of themselves they prefer.

Personality pharmacology begins by taking that preference seriously, then asks whether the route to it increases long-term agency or quietly consumes it.

To answer that, we need the central law in its most explicit form: the effect of a drug depends on the system it enters.